Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Arteriosclerosis Thrombosis and Vascular Biology

DOI: 10.1161/atv.0000000000000147 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 7 stored of 774

Lipoprotein(a) and residual cardiovascular risk in statin-treated patients
2026 European Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health

2

citations
Safety of low lipoprotein(a) levels: the FOURIER trial
2026 European Heart Journal article Medicine Lipoproteins and Cardiovascular Health

2

citations
Interlaboratory comparison of serum lipoprotein(a) analytical results across clinical assays—Steps toward standardization
2025 Journal of clinical lipidology article Medicine Lipoproteins and Cardiovascular Health Open access

8

citations
Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples
2025 Clinical Chemistry and Laboratory Medicine (CCLM) article Medicine Clinical Laboratory Practices and Quality Control Open access

21

citations
An LC–MS-based designated comparison method with similar performance to the Lp(a) reference measurement procedure to guide molar Lp(a) standardization
2024 Clinical Proteomics article Medicine Lipoproteins and Cardiovascular Health Open access

8

citations
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
2023 Circulation article Medicine Lipoproteins and Cardiovascular Health Open access

60

citations
On the Way to a Next-Generation Lp(a) Reference Measurement System Based on Quantitative Protein Mass Spectrometry and Molar Units
2023 Contemporary cardiology book-chapter Medicine Lipoproteins and Cardiovascular Health

4

citations

7 results

References 4

4 results